- recruitingPhase II
A study to investigate a tailor-made device designed to insert an intrauterine contraceptive device (IUD) immediately after childbirth
This study looks at a new, specially designed plastic tool to insert an IUD (coil) after childbirth. It aims to see if this new tool makes the process easier and more comfortable than current methods. This could help more women access contraception after having a baby.
United Kingdom · Scotland - authorisedTherapeutic use (Phase IV)
CoCo-PCOS - Comprehensive Health Effects of Combined Contraceptives: a 6-month randomized, controlled, open-label trial of E4+DRSP, EE20µg+DRSP, and DRSP-only in women with PCOS
This study looks at how different birth control pills affect women with Polycystic Ovary Syndrome (PCOS) over six months. We want to see how these common medications impact their overall health and symptoms.
Finland - active not recruiting
European Active Surveillance Study of LCS12
This study is looking at a new type of coil (LCS12) to see how well it prevents pregnancy compared to other popular coils like Mirena and copper IUDs. It also checks for any common side effects, like infections or the coil moving out of place.
Germany - authorisedTherapeutic use (Phase IV)
CoCo3 - Comprehensive Health Effects of Combined Contraceptives: a 12-month randomized, controlled, open-label trial of E4+DRSP, EE20μg+DRSP and DRSP-only
This study looks at different contraceptive pills to understand their effects on women's health over 12 months. It compares new and existing pills to see how they work.
Finland - ongoing, recruitingTherapeutic use (Phase IV)
Brain effects of hormonal contraceptives. A randomized, double-blind, longitudinal study comparing two combined oral contraceptives (Estetrol/drospirenone vs ethinylestradiol/levonorgestrel).
This study looks at how different hormone birth control pills affect the brain in women. Researchers want to see if specific brain areas change when taking one of two common contraceptive pills, and how this might relate to mood.
Sweden - ongoing, recruitingTherapeutic confirmatory (Phase III)
WOMEN&More: Prospective phase III multi-center open-label study of the efficacy, safety, and acceptability of mifepristone 50 mg once-weekly as a contraceptive
Researchers are studying a new once-a-week pill that could help prevent pregnancy. This study, called WOMEN&More, is looking at how well a 50mg dose of mifepristone works, if it's safe, and if women find it easy to use compared to current birth control.
Netherlands